Skip Navigation


Rheumatology Advance Access originally published online on April 27, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
43/7/839    most recent
keh193v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wei, J. C. C.
Right arrow Articles by Chou, C. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, J. C. C.
Right arrow Articles by Chou, C. T.
Related Collections
Right arrow Spondylarthropathies
Right arrow Immunogenetics
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2004; 43: 839-842
Rheumatology Vol. 43 No. 7 © British Society for Rheumatology 2004; all rights reserved


Paper

HLA-B60 and B61 are strongly associated with ankylosing spondylitis in HLA-B27-negative Taiwan Chinese patients

J. C. C. Wei, W. C. Tsai1, H. S. Lin2, C. Y. Tsai3 and C. T. Chou3

Division of Allergy, Immunology and Rheumatology, Department of Internal Medicine and Institute of Medicine, Chung Shan Medical University, Taichung, 1 Department of Medicine, Kaohsiung Medical University Hospital, 2 Department of Nursing Management, Fooyin University, Kaohsiung and 3 Division of Allergy-Immunology-Rheumatology, Veterans General Hospital, Taipei, Taiwan.

Correspondence to: C. T. Chou, Division of Allergy-Immunology-Rheumatology, Veterans General Hospital-Taipei, No. 201, Sec. 2, Shpai Road, Beitou Chiu, Taipei, Taiwan 112. E-mail: ctchou{at}vghtpe.gov.tw

Objectives. Carriage of HLA-B60 has been shown to increase the risk of ankylosing spondylitis (AS) in B27-positive Caucasian patients, but the association in B27-negative cases is less certain. This study assessed HLA class I gene associations in Chinese HLA-B27-negative AS patients.

Methods. Forty-one Chinese HLA-B27-negative AS patients fulfilling the modified New York diagnostic criteria for AS were recruited, and 11 383 HLA-B27-negative blood donors were used for comparison. HLA-A and -B typing was done with the microlymphocytotoxicity assay.

Results. Among the B27-negative AS patients, 21 were male and 20 were female. Of HLA-B alleles, only B60 and B61 significantly increased susceptibility to AS in HLA-B27-negative patients (P<0.001).

Conclusions. In Taiwan Chinese, carriage of B60 is increased in HLA-B27-negative AS patients. The association between B61 and HLA-B27-negative AS patients has not been reported previously. Whether the gene involved is HLA-B60 or B61 or another gene in linkage disequilibrium with these genes is unknown.

KEY WORDS: Ankylosing spondylitis, HLA-B27-negative, HLA-class I genes


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Rheumatology (Oxford)Home page
M. A. Brown
Breakthroughs in genetic studies of ankylosing spondylitis
Rheumatology, February 1, 2008; 47(2): 132 - 137.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
M.-Y. Shiau, M.-K. Lo, C.-P. Chang, T.-P. Yang, K.-T. Ho, and Y.-H. Chang
Association of tumour necrosis factor {alpha} promoter polymorphisms with ankylosing spondylitis in Taiwan
Ann Rheum Dis, April 1, 2007; 66(4): 562 - 563.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.